scPharmaceuticals Inc (SCPH)
3.04
-0.01
(-0.33%)
USD |
NASDAQ |
Mar 19, 14:44
scPharmaceuticals Enterprise Value: 112.24M for March 18, 2025
View 4,000+ Financial Data Types:
Add
Browse
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Regenxbio Inc | 155.98M |
| BioXcel Therapeutics Inc | 71.52M |
| NovaBay Pharmaceuticals Inc | 2.359M |
| Palatin Technologies Inc | 17.26M |
| Theriva Biologics Inc | -8.145M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -35.10M |
| Revenue (Quarterly) | 10.03M |
| Total Expenses (Quarterly) | 28.17M |
| EPS Diluted (Quarterly) | -0.75 |
| Gross Profit Margin (Quarterly) | 66.98% |
| Profit Margin (Quarterly) | -350.1% |
| Earnings Yield | -62.50% |
| Normalized Earnings Yield | -53.29 |